Reducing bone erosion in Rheumatoid Arthritis, using the body’s own cannabinoids

Directly targeting the body’s endo-cannabinoid system may slow down or stop bone erosion in Rheumatiod Arthritis, according to researchers at the Children’s Hospital of Soochow University in Suzhou, China.

The experimental research, using laboratory mice, found that some of the cannabinoid receptors in the body don’t work properly.

Certain cannabinoids that are naturally produced in the body (endo-cannabinoids) were “activated” and then applied to the deficient receptors.

“Many members of the endocannabinoid system are reported to inhibit synovial inflammation, hyperplasia, and cartilage destruction in RA,” says the study.

The endocannabinoid system and its therapeutic implications in rhuematoid arthritis was published in the International Immunopharmacology journal in May 2015.

Copyright Notice © 2018. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to with appropriate and specific direction to the original content.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s